A clinical trial of edrecolomab, interleukin-2 and GM-CSF in patients with advanced colorectal cancer

Oncology Reports

Volumn 8, Issue 2, 2001, Pages 225-231

  Fiedler, Walter ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Colorectal carcinoma; Edrecolomab; GMCSF; Intcrleukin 2; Monoclonal antibody

Indexed keywords

EDRECOLOMAB; INTERLEUKIN 2; MONOCLONAL ANTIBODY; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

AGED; ARTICLE; CLINICAL TRIAL; COLON TUMOR; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; RECTUM TUMOR; SURVIVAL RATE; TIME; TREATMENT FAILURE;

AGED; ANTIBODIES, MONOCLONAL; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; INTERLEUKIN-2; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RECTAL NEOPLASMS; SURVIVAL RATE; TIME FACTORS; TREATMENT FAILURE;

EID: 0035286221     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.8.2.225     Document Type: Article

References (3)

1. Poon MA, O'Conell MJ, Wienand HS, Krook JE, Gerstncr JB, Tschetter LK, Lcvitt R, Kardinal CG and Mailliard JA: Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficiency in advanced colorectal cancer. J Clin Oncol 9: 1967-1972, 1991.
2. Douillard JY, Cunningham D, Roth AD, Germa JR, James RD, Karasck P, Jandik P, Iveson T, Carmichael J, Gruia G, Dembak M, Sibaud D and Rougier P: A randomized phase III trial comparing irinotecan (IRI) + 5FU/Folinic acid (FA) to the same schedule of 5FU/FA in patients with metastatic colorectal cancer as front line chemotherapy. J Clin Oncol 18: A899, 1999.
3. Riethmuller G, Schneider-Gaedicke E, Schlimok G, Schmiegcl W, Raab R, Hoeffken K, Grubcr R, Pichlmaier H, Hirche H and Pichlmayr R: Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes'C colorectal carcinoma. Lancet 343: 1177-1183, 1994.